110 filings
Page 3 of 6
8-K
5up7ia4pwqr7uqgvdl
12 Jun 20
Entry into a Material Definitive Agreement
4:20pm
8-K
ffq0u 1bquh9x84q
8 Jun 20
Rocket Pharmaceuticals Announces Private Exchange Transaction
7:10am
8-K
id91gk3
1 May 20
Other Events
12:00am
8-K
h5n7 kf6r
22 Apr 20
Departure of Directors or Certain Officers
4:16pm
8-K
tc3q4z
20 Feb 20
Entry into a Material Definitive Agreement
5:20pm
8-K
tu5vovz5e48c54
11 Feb 20
Rocket Pharmaceuticals Announces Private Exchange Transactions Regarding Outstanding Convertible Senior Notes due 2021
5:26pm
8-K
8qoh47 d1x14nlzhf9f
13 Dec 19
Entry into a Material Definitive Agreement
4:02pm
8-K
7jn 4mocs8uffn4ke
31 Oct 19
Departure of Directors or Certain Officers
4:02pm
8-K
9dzw5cveoft
19 Jun 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:20pm
8-K
87i7 tlmdk2fby15zy
19 Jun 19
Submission of Matters to a Vote of Security Holders
4:19pm
8-K
tyz16
18 Apr 19
Entry into a Material Definitive Agreement
4:03pm
8-K
v0y4dx2wahva
28 Dec 18
Other Events
5:05pm
8-K
2s1ugdt
29 Nov 18
Entry into a Material Definitive Agreement
4:01pm
8-K
r8iu1eo icl20xhbd
26 Nov 18
Regulation FD Disclosure
4:16pm
8-K
q5khc2hz
26 Nov 18
Rocket Pharmaceuticals and REGENXBIO Announce New License Agreement for the Treatment of Danon Disease Using NAV AAV9 Vector
4:02pm
8-K
0igx9gd6ccocm4dp
25 Jun 18
Departure of Directors or Certain Officers
4:35pm
8-K
kitxi
18 May 18
Regulation FD Disclosure
4:01pm
8-K
5m3pyn
4 Apr 18
Departure of Directors or Certain Officers
12:00am
8-K
rhbuem
21 Mar 18
Changes in Registrant's Certifying Accountant
12:00am
8-K
rte0wmm
7 Mar 18
Rocket Pharmaceuticals Reports Full Year 2017 Financial Results and Operational Highlights
12:00am